Mineralys Therapeutics, Inc. (MLYS)
33.22
-2.12
(-6.01%)
USD |
NASDAQ |
Jan 08, 16:00
33.48
+0.26
(+0.77%)
After-Hours: 20:00
Mineralys Therapeutics Market Cap: 2.629B for Jan. 8, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Insmed, Inc. | 36.33B |
| Nektar Therapeutics | 715.03M |
| Lyell Immunopharma, Inc. | 361.32M |
| Arrowhead Pharmaceuticals, Inc. | 8.822B |
| Cidara Therapeutics, Inc. | 6.962B |
Market Cap Related Metrics
| Price to Book Value | 4.562 |
| Price | 33.22 |
| Earnings Yield | -8.90% |